Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?
7/19/2011
More...
|
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study
1/28/2011
More...
|
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study
12/30/2010
More...
|
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial
12/13/2010
More...
|
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study
12/7/2010
More...
|
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study
11/11/2010
More...
|
American Association for Study of Liver Diseases: Early Study Shows HCV Vaccine Works, Scripps Clinic Study
11/3/2010
More...
|
American Association for Study of Liver Diseases: Rapid Response for Once-Daily Protease Inhibitor, University of North Carolina Study
11/3/2010
More...
|
American Academy of Ophthalmology: Glaucoma Drug Passes Early Clinical Test
10/21/2010
More...
|
Ceregene, Inc. Initiates a New Controlled Phase 2b Trial of Cere-120 for Parkinson's Disease
10/19/2010
More...
|
American Society for Bone and Mineral Research: Novel Drug Promising in Osteoporosis, University of Erlangen Study Reveals
10/19/2010
More...
|
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression
10/19/2010
More...
|
ESMO: New Agent Active in Advanced Ovarian Cancer, Dana-Farber Cancer Institute Study
10/15/2010
More...
|
ESMO: No Help from PARP Inhibitor in Ovarian Cancer, Royal Marsden Hospital Study
10/14/2010
More...
|
New Targeted Therapy Adds Benefit to Erlotinib in Some Patients with Advanced Lung Cancer, Sarah Cannon Research Institute Study
10/11/2010
More...
|
Clinical Trial Tests Targeting Prostate Cancer Treatment, University of Michigan Health System Study
5/24/2013
More...
|
La Jolla Pharmaceutical Company (LJPC) Releases Data Indicating GCS-100 May Improve Renal Function
5/24/2013
More...
|
OncoGenex Pharmaceuticals Inc. Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination With Chemotherapy in Advanced Squamous Cell Lung Cancer
5/23/2013
More...
|
Lightlake Therapeutics Inc. (LLTP)’ Binge Eating Disorder Treatment Phase II Trial Results Presented at American Psychiatric Association 2013 Annual Meeting
5/23/2013
More...
|
Lpath, Inc. Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
5/23/2013
More...
|
Merrimack Pharmaceuticals Inc. Completes Enrollment in a Phase 2 Study of MM-121 in Combination With Exemestane in Breast Cancer
5/23/2013
More...
|
Repros Therapeutics Inc. (RPRX) Release: FDA Recommends Running Phase 2b Trial of Proellex®-V in the Treatment of Severe Menstrual Bleeding Associated With Uterine Fibroids
5/23/2013
More...
|
Oncolytics Biotech Inc. (ONC.TO) Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial
5/22/2013
More...
|
Rigel Pharmaceuticals, Inc. (RIGL)'s R348 to Initiate Phase 2 Clinical Trial in Dry Eye
5/22/2013
More...
|
Prosonix Initiates Phase 2 Clinical Study With PSX1002 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
5/22/2013
More...
|
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Announces Initiation of Enrollment in National Cancer Institute-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors
5/22/2013
More...
|
Ceregene, Inc. Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study
5/21/2013
More...
|
Jennerex, Inc. Announces Completion of Enrollment in Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
5/21/2013
More...
|
Multiple Target ALS Drug Ready for Genervon's Phase 2 Trial
5/21/2013
More...
|
Verona Pharma Release: Further Clinical Data Highlighting the Significant Bronchodilator Activity of Novel Dual PDE3/4 Inhibitor RPL554 Presented at American Thoracic Society International Conference
5/21/2013
More...
|